PTGIS
protein-codingprostaglandin I2 synthase, the group of Cytochrome P450 family 8
Gene summary
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to prostacyclin (prostaglandin I2), a potent vasodilator and inhibitor of platelet aggregation. An imbalance of prostacyclin and its physiological antagonist thromboxane A2 contribute to the development of myocardial infarction, stroke, and atherosclerosis. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~64.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0007781
Submitter: Labcorp Genetics (formerly Invitae)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PTGIS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000961.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | 4 | ||
| missense | 1 | 93 | 4 | 1 | 99 | |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 1 | 1 | 97 | 5 | 3 | 107 |
Highest pathogenic variant AF is 0.001178278
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000952.1 | 10 | MANE Select | |
| Ensembl | ENSP00000244043.3 | 10 | MANE Select | |
| Ensembl | ENSP00000588320.1 | 8 | Standard | |
| Ensembl | ENSP00000588320.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Arachidonic acid metabolism - Homo sapiens (human)
- Phenytoin Pathway, Pharmacokinetics
- Celecoxib Pathway, Pharmacodynamics
- Etodolac Action Pathway
- Ketoprofen Action Pathway
Biological Process
- prostaglandin biosynthetic process
- icosanoid metabolic process
- embryo implantation
- cyclooxygenase pathway
- negative regulation of NF-kappaB transcription factor activity
Molecular Function
- monooxygenase activity
- iron ion binding
- protein binding
- prostaglandin-I synthase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
Cellular Component
- extracellular space
- nucleus
- endoplasmic reticulum
- endoplasmic reticulum membrane
- caveola
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000244043
- Coding exons
- 10
- Length
- 64273
- Individuals with no LoFs
- 125624
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 124
- Defined
- 125748
- p
- 0.000493
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.369 | 310 | 292 | 1.06 | 0.0000192 | 3248 |
| Missense (PolyPhen) | 100 | 101.94 | 0.98101 | 1169 | ||
| Synonymous | -0.333 | 127 | 122 | 1.04 | 0.00000833 | 1020 |
| Loss of Function | 1.19 | 17 | 23.2 | 0.733 | 0.00000137 | 240 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00038 | 0.00038 | rare |
| Ashkenazi Jewish | 0.0020 | 0.0020 | notable |
| East Asian | 0.00098 | 0.00098 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00045 | 0.00041 | rare |
| South Asian | 0.00049 | 0.00049 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the isomerization of prostaglandin H2 to prostacyclin (= prostaglandin I2). {ECO:0000269|PubMed:18032380, ECO:0000269|PubMed:25623425}.;
Recessive Scores
- pRec
- 0.277
Intolerance Scores
- LoFtool
- 0.936
- RVIS EVS
- -0.35
- RVIS percentile EVS
- 29.49
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.929
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |